ArticleJournal of nephrology2023

Sotrovimab in SARS-COV-2 chronic hemodialysis patients in the Omicron era. Is intradialytic administration feasible? Report of 4 cases.

Emanuele Mambelli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.